Afrouz Nayernama

发表

Wound healing complications with lenvatinib identified in a pharmacovigilance database

P. Waldron, Connie Cheng, Afrouz Nayernama, 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Ibrutinib-associated ventricular arrhythmia in the FDA Adverse Event Reporting System

Connie Cheng, Afrouz Nayernama, D. Woronow, 2018, Leukemia & lymphoma.

Abiraterone acetate-associated QT prolongation and torsades de pointes: Postmarketing cases reported to FDA

Afrouz Nayernama, S. Christopher Jones, D. Woronow, 2021, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Proteasome inhibitor‐associated thrombotic microangiopathy: A review of cases reported to the FDA adverse event reporting system and published in the literature

P. Waldron, B. Kanapuru, Afrouz Nayernama, 2020, American journal of hematology.

Postmarketing Colitis Cases Associated With Alpelisib Use Reported to the US Food and Drug Administration.

Tatiana M. Prowell, G. Dores, Kathleen M Sullivan, 2022, JAMA Oncology.

BCR‐ABL1 tyrosine kinase inhibitor‐associated thyroid dysfunction: A review of cases reported to the FDA Adverse Event Reporting System and published in the literature

P. Waldron, R. A. de Claro, Afrouz Nayernama, 2020, American journal of hematology.

Arterial aneurysm and dissection with systemic vascular endothelial growth factor inhibitors: A review of cases reported to the FDA Adverse Event Reporting System and published in the literature

L. Amiri-Kordestani, Connie Cheng, Afrouz Nayernama, 2021, Vascular medicine.

Hemolytic anemia following alectinib reported to the U.S. Food and Drug Administration Adverse Event Reporting System

G. Dores, Connie Cheng, Afrouz Nayernama, 2022, American journal of hematology.

U.S. Food and Drug Administration Analysis of Newly Identified Adverse Events With Lurbinectedin: Extravasation, Rhabdomyolysis, and Tumor Lysis Syndrome.

G. Dores, Afrouz Nayernama, S. Camilli, 2022, Clinical lung cancer.